Caribou Biosciences

Allogeneic CAR-T biotechs fight to escape 'nuclear winter'

As autologous CAR-T continues to improve and Big Pharma pumps big cash into next-gen approaches, is there room left at the table for allogeneic CAR-T?

Darren Incorvaia Feb 11, 2026 11:00am

Appeals court reignites row over CRISPR discovery

May 13, 2025 8:00am

Caribou antlers sitting on ground with mountains in background

Caribou cuts 32% of staff, further purges cell therapy pipeline

Apr 24, 2025 9:55pm

Vincerx acquisition leads to C-suite shake-up—Chutes & Ladders

Jan 3, 2025 8:30am

CRISPR-focused Caribou christens new CMO—Chutes & Ladders

Aug 16, 2024 8:30am

Caribou cuts NK program, lays off 12% to fund CAR-T trials

Jul 17, 2024 5:41am